These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12366715)

  • 1. Acute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution?
    Radaelli F; Mazza R; Curioni E; Ciani A; Pomati M; Maiolo AT
    Eur J Haematol; 2002 Aug; 69(2):108-11. PubMed ID: 12366715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic GpIIb-IIIa and cytokine secretion by blasts in a case of megakaryoblastic transformation of essential thrombocythemia.
    Selleri C; Alfinito F; Del Vecchio L; Luciano L; De Renzo A; Rotoli B
    Leuk Lymphoma; 1993 Aug; 10(6):497-500. PubMed ID: 8401187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute megakaryoblastic transformation of essential thrombocythemia.
    Vianelli N; Baravelli S; Gugliotta L
    Haematologica; 1996; 81(3):288-9. PubMed ID: 8767538
    [No Abstract]   [Full Text] [Related]  

  • 4. Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia.
    Michiels JJ; Prins ME; Hagermeijer A; Brederoo P; van der Meulen J; van Vliet HH; Abels J
    Am J Clin Pathol; 1987 Nov; 88(5):645-52. PubMed ID: 3479003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukaemia with trisomy 8, trisomy 21 and cutaneous involvement.
    Paolini R; Bonaldi L; Bianchini E; Ramazzina E; Cella G
    Eur J Haematol; 2003 Dec; 71(6):466-9. PubMed ID: 14703699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
    Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
    Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
    [No Abstract]   [Full Text] [Related]  

  • 7. Megakaryoblastic transformation of essential thrombocythemia, hypercalcemia and lytic bone lesions.
    Vinti H; Taillan B; Pesce A; Michiels JF; Bayle J; Cassuto JP
    Acta Haematol; 1990; 83(1):53. PubMed ID: 2105572
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent.
    Higuchi T; Okada S; Mori H; Niikura H; Omine M; Terada H
    Cancer; 1995 Jan; 75(2):471-7. PubMed ID: 7812918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia with megakaryocytic differentiation following essential thrombocythemia and myelofibrosis. Case report and review of the literature.
    Patiño-Sarcinelli F; Knecht H; Pechet L; Pihan G; Savas L; Snyder LM
    Acta Haematol; 1996; 95(2):122-8. PubMed ID: 8638441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation--a brief review of recent literature.
    Shibata K; Shimamoto Y; Suga K; Sano M; Matsuzaki M; Yamaguchi M
    Acta Haematol; 1994; 91(2):84-8. PubMed ID: 8023650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7.
    Peterson BA; Levine EG
    Semin Oncol; 1987 Dec; 14(4):425-34. PubMed ID: 3321447
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
    Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO
    Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute megakaryocytic leukemia (AMKL,FAB;M7) with Beckwith-Wiedemann syndrome.
    Yamamoto S; Toyama D; Yatsuki H; Higashimoto K; Soejima H; Isoyama K
    Pediatr Blood Cancer; 2010 Oct; 55(4):733-5. PubMed ID: 20589645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute megakaryoblastic leukemia developing 11 years after diagnosis of essential thrombocythemia].
    Miyoshi Y; Okada S; Takizawa Y; Hagiwara S; Mori H; Niikura H; Terada H; Fujita K
    Rinsho Ketsueki; 1991 Aug; 32(8):868-73. PubMed ID: 1942527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment.
    Andersson PO; Ridell B; Wadenvik H; Kutti J
    Ann Hematol; 2000 Jan; 79(1):40-2. PubMed ID: 10663620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Megakaryocytic myelosis: clinical and morphological features (author's transl)].
    Prechtel K; Beil E; Kronseder A
    Dtsch Med Wochenschr; 1977 Jun; 102(23):853-7. PubMed ID: 266986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary myelofibrosis terminating in megakaryoblastic crisis.
    Kurashima K; Kawamura Y; Ohka T; Hayashi M; Matsuda T
    Jpn J Med; 1990; 29(2):226-9. PubMed ID: 2232372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.